A novel stilbene derivative targets RAD51 activity and sensitizes DU145 prostate cancer cells to cisplatin
- DOI
- 10.1016/j.bcp.2026.118393
- Published
- 2026-12
- Container
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bcp.2026.118393,
title = {A novel stilbene derivative targets RAD51 activity and sensitizes DU145 prostate cancer cells to cisplatin},
author = {Lucie Fonteneau and Houda Benhelli-Mokrani and Céline Robiou Du Pont and Damien Marquis and Jacques Lebreton and Monique Mathé-Allainmat and Benoît Chénais and Fabrice Fleury},
year = {2026},
journal = {Biochemical Pharmacology},
doi = {10.1016/j.bcp.2026.118393},
url = {https://doi.org/10.1016/j.bcp.2026.118393}
}RIS
TY - JOUR TI - A novel stilbene derivative targets RAD51 activity and sensitizes DU145 prostate cancer cells to cisplatin AU - Lucie Fonteneau AU - Houda Benhelli-Mokrani AU - Céline Robiou Du Pont AU - Damien Marquis AU - Jacques Lebreton AU - Monique Mathé-Allainmat AU - Benoît Chénais AU - Fabrice Fleury PY - 2026 JO - Biochemical Pharmacology DO - 10.1016/j.bcp.2026.118393 UR - https://doi.org/10.1016/j.bcp.2026.118393 ER -
APA
Fonteneau, L., Benhelli-Mokrani, H., Pont, C. R. D., Marquis, D., Lebreton, J., Mathé-Allainmat, M., Chénais, B., & Fleury, F. (2026). A novel stilbene derivative targets RAD51 activity and sensitizes DU145 prostate cancer cells to cisplatin. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118393
Source records
- crossref · retrieved 2026-09-26T15:41:11.331Z